Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 904.77 $ -1.21 (-0.13 %)    

Wednesday, 18-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 904.97
$ 776.75 x 105
-- x --
-- - --
$ 513.12 - $ 972.53
1,776,976
na
860.11B
$ 0.59
$ 117.15
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

looking-into-eli-lillys-recent-short-interest
Looking Into Eli Lilly's Recent Short Inte...
09/17/2024 20:45:14

unpacking-the-latest-options-trading-trends-in-eli-lilly
Unpacking the Latest Options Trading Trend...
09/17/2024 14:16:12

eli-lilly-scores-fda-approval-for-eczema-treatment-ebglyss
Eli Lilly Scores FDA Approval For Eczema T...
09/16/2024 17:36:43

The FDA has approved Eli Lilly's Ebglyss for moderate-to-severe eczema in patients 12 and older. The treatment is administe...

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/16/2024 16:05:57

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly (NYSE:LLY) with a Overweight and maintains $885 price target.

fda-approves-lillys-ebglyss-for-adults-and-children-12-years-and-older-with-moderate-to-severe-atopic-dermatitis
FDA Approves Lilly's Ebglyss For Adults An...
09/13/2024 20:08:48

correction-jp-morgan-maintains-overweight-on-eli-lilly-raises-price-target-to-1100-action-price-target-changed-to-raises
Correction: JP Morgan Maintains Overweight...
09/13/2024 16:39:31

Correction: JP Morgan analyst Chris Schott maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1...

jp-morgan-maintains-overweight-on-eli-lilly-lowers-price-target-to-1100
JP Morgan Maintains Overweight on Eli Lill...
09/13/2024 15:41:01

JP Morgan analyst Chris Schott maintains Eli Lilly (NYSE:LLY) with a Overweight and lowers the price target from $1050 to $1...

citigroup-reinstates-buy-on-eli-lilly-announces-1060-price-target
Citigroup Reinstates Buy on Eli Lilly, Ann...
09/13/2024 13:44:27

Citigroup analyst Peter Verdult reinstates Eli Lilly (NYSE:LLY) with a Buy and announces $1060 price target.

looking-at-eli-lillys-recent-unusual-options-activity
Looking At Eli Lilly's Recent Unusual Opti...
09/12/2024 19:32:46

eli-lilly-pumps-800m-into-irish-operations-to-meet-skyrocketing-demand-for-mounjaro-zepbound
Eli Lilly Pumps $800M Into Irish Operation...
09/12/2024 14:05:57

The investment is aimed at ensuring a steady supply of the drugs, which have been grappling with shortages since 2022.

unpacking-the-latest-options-trading-trends-in-eli-lilly
Unpacking the Latest Options Trading Trend...
09/12/2024 14:03:16

eli-lilly-boosts-manufacturing-investment-in-limerick-ireland-by-1b-unveils-new-800m-kinsale-facility
Eli Lilly Boosts Manufacturing Investment ...
09/12/2024 09:31:47

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 202...

Core News & Articles
Roche Says In CT-996 Phase 1 Trial, 4-Week...
09/11/2024 15:49:52

- Reuters

could-elon-musk-become-the-worlds-first-trillionaire-teslas-success-could-make-it-happen-as-early-as
Could Elon Musk Become The World's First T...
09/11/2024 13:32:04

A new study predicts Elon Musk will become the world's first trillionaire if Tesla can regain the $1 trillion market cap le...

ozempic-maker-novo-nordisk-touts-encouraging-data-from-new-obesity-pill-showing-double-weight-loss-compared-to-wegovy
Ozempic Maker Novo Nordisk Touts Encouragi...
09/11/2024 13:13:52

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight loss...

novo-nordisk-reports-positive-results-of-weight-loss-drug-liraglutide-for-children-as-young-as-6-eyes-fda-and-ema-approval
Novo Nordisk Reports Positive Results Of W...
09/11/2024 08:19:30

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The compan...

heres-how-much-you-would-have-made-owning-eli-lilly-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
09/10/2024 20:00:20

eli-lillys-once-weekly-insulin-efsitora-alfa-achieves-comparable-a1c-reduction-to-daily-insulin-degludec-in-phase-3-qwint-2-trial-results-published-in-nejm-and-presented-at-easd-2024-efsitora-reduced-a1c-by-134-compared-to-126-for-insulin-degludec
Eli Lilly's Once-Weekly Insulin Efsitora A...
09/10/2024 15:27:54

In QWINT-2, efsitora helped adults naïve to insulin therapy currently using and not using GLP-1 receptor agonists achieve an A1...

zepbound-and-mounjaro-maker-eli-illy-has-a-new-cfo-as-it-navigates-regulatory-challenges-what-you-should-know
Zepbound And Mounjaro Maker Eli Illy Has A...
09/10/2024 03:00:59

Eli Lilly and Company has appointed Lucas Montarce as executive vice president and chief financial officer, effective immediate...

a-glimpse-into-the-expert-outlook-on-eli-lilly-through-28-analysts
A Glimpse Into The Expert Outlook On Eli L...
09/09/2024 20:00:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION